Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Return on Equity [ROE] (2013 - 2026)

Updated

Skye Bioscience (SKYE) posted Return on Equity [ROE] of -1186.04% for Q2 2026, down 1103.70 percentage points from -82.34% a year earlier and down 791.14 percentage points from the prior quarter.

Analysis

Skye Bioscience (SKYE) Return on Equity [ROE] (2013 - 2026) Analysis & Trends

For FY2025, Skye Bioscience's Return on Equity [ROE] came in at -126.85%, down 46.37 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +1186.81 percentage points (FY2020 to FY2025).
  • In prior years, Skye Bioscience's Return on Equity [ROE] was -80.48% in FY2024, -1364.20% in FY2022 (-1094.30 pp) and -269.90% in FY2021 (+1043.75 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2014.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -284.58 percentage points over the last six quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 451.95 percentage points; the weakest was Q2 2026, with a drop of 1103.70 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -394.90% (Q1 2026), -211.59% (Q4 2025) and -133.91% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 19.33%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.63%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 21.60%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -31.17%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.66%
10 Skye Bioscience 5.38 Mn -52.34 Mn - -8,728.70%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -8,728.70%
Jun 30, 2026 -1,186.04%
Mar 31, 2026 -394.90%
Dec 31, 2025 -211.59%
Sep 30, 2025 -133.91%
Jun 30, 2025 -82.34%
Mar 31, 2025 -51.26%
Dec 31, 2024 -36.91%
Sep 30, 2024 -28.59%
Jun 30, 2024 -55.76%
Mar 31, 2024 -97.71%
Jun 30, 2022 -808.63%
Mar 31, 2022 -212.85%
Dec 31, 2021 -120.63%
Sep 30, 2021 -142.59%
Jun 30, 2021 -294.05%
Mar 31, 2021 -435.55%
Dec 31, 2020 -569.47%
Dec 31, 2014 -1,684.07%
Oct 31, 2013 -5.39%
API Access

Skye Bioscience Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SKYE&period=max&api_key=YOUR_API_KEY